Starting soon
Not applicable
Impact of the Receptive Music Intervention Tool (MUSIC CARE©) on Changes in the Functional Abilities of Patients With Chronic Low Back Pain
Condition(s) studied
Low Back Pain Kinesiophobia (Fear of Movement) Chronic Low-back Pain (cLBP)
Investigational drug(s) / intervention(s)
Receptive Music Therapy
Receptive Music Therapy: MUSIC CARE© is a Class 1 validated medical device delivering personalized receptive music therapy based on hypnoanalgesia principles. Each session follows a standardized "U-sequence" protocol comprising three phases: an induction phase with gradually decreasing tempo and orchestral complexity; a deep relaxation phase with slow tempo and minimal instrumentation; and a progressive awakening phase. Sessions are set at 20 minutes, administered daily before standard rehabilitation sessions throughout the 5-to-6-week day hospital stay. The sequence is pre-personalized by the investigator according to participant musical preferences collected at inclusion. The participant is seated alone in a dedicated room, wearing headphones connected to the MUSIC CARE© tablet.
Study summary
Brief Summary The goal of this clinical trial is to learn if MUSIC CARE©, a music-based therapy tool, can improve the physical abilities of people with chronic low back pain (back pain that lasts more than 3 months).
The main questions it aims to answer are:
Does MUSIC CARE© help participants better perform their daily activities? Does MUSIC CARE© lower the fear of movement in participants? Does MUSIC CARE© help participants return to work?
Why this study? Chronic low back pain is a leading cause of disability and absence from work. Physical rehabilitation is the recommended treatment. However, many participants develop a fear of movement. This fear slows down their recovery and limits the benefits of rehabilitation.
MUSIC CARE© is a digital music tool. It uses specially designed music to help participants relax and feel less pain. Researchers believe that using MUSIC CARE© before rehabilitation sessions may help participants move more freely and recover better.
How does the study work?
Researchers will compare two groups of participants:
Group 1: follows a standard rehabilitation program with MUSIC CARE© Group 2: follows a standard rehabilitation program without MUSIC CARE© This comparison will show whether MUSIC CARE© brings added benefits.
Participants will:
Take part in a rehabilitation program for 5 to 6 weeks Use MUSIC CARE© before each therapy session (Group 1 only). Complete questionnaires about their pain, fear of movement, and ability to perform daily activities.
Be followed for 6 months after the program ends, including an assessment of their return to work.
What could this study change? If results are positive, this study could confirm that MUSIC CARE© is a useful non-drug tool to support rehabilitation for people with chronic low back pain. It could help bring this approach into standard care programs, with no additional medication.
Eligibility
Inclusion Criteria:
* Diagnosed with chronic low back pain by a Physical Medicine and Rehabilitation (PMR) physician, defined as lumbar pain and/or pain radiating to the lower limb that affects daily and professional activities and has lasted more than 3 months
* If surgery was performed, it must have been done at least 3 months before entering the study
* Adult (18 years of age or older) admitted to the day hospital at Clinique Saint-Roch for a chronic low back pain rehabilitation program
* Considered able to return to work, as assessed by the PMR physician during the pre-admission consultation, with no medical contraindication to resuming professional activity
* Affiliated with a French social security scheme
* Has given written informed consent to participate in the study
Exclusion Criteria:
* Hearing impairment that would prevent the use of the MUSIC CARE© device
* Medical contraindication to hydrotherapy (balneotherapy)
* Symptomatic disc herniation
* Vertebral fracture or history of recent vertebral fracture within the past 2 years
* Unstable spondylolisthesis
* Disc-vertebral infection (spondylodiscitis)
* Inflammatory rheumatic disease such as ankylosing spondylitis (spondyloarthritis) or rheumatoid arthritis
* Constitutional connective tissue disorder such as Ehlers-Danlos syndrome or Marfan syndrome
* Severe, unstabilized, or decompensated psychiatric disorder, including psychotic disorders, acute-phase bipolar disorder, or severe major depressive episode
* Central nervous system neurological disease such as multiple sclerosis, stroke, or Parkinson's disease
* Peripheral neuropathy of the lower limbs
* Unstabilized cardiovascular disease
* Active cancer treatment or cancer diagnosis within the past 2 years
* Surgery for a reason other than low back pain within the past 6 months
* Currently retired (not in active employment)
* Currently enrolled in another interventional research study
* Persons under legal protection as defined by Articles L.1121-5 to L.1121-8 of the French Public Health Code, including:
* Persons under guardianship, curatorship, or judicial protection
* Minors (under 18 years of age)
* Pregnant or breastfeeding women
* Any person subject to a legal protection measure or unable to freely provide informed consent
Primary outcome measure(s)
Change from Baseline in Functional Disability as Assessed by the EIFEL Questionnaire at End of Stay — Baseline (Day 1) and end of stay (Weeks 5 to 6) The EIFEL (Échelle d'Incapacité Fonctionnelle pour l'Évaluation des Lombalgies) is a validated 24-item self-administered questionnaire, adapted from the Roland-Morris Disability Questionnaire. Each item is answered yes (1) or no (0). The total score ranges from 0 to 24, where 0 indicates no functional disability and 24 indicates maximum functional disability. A higher score reflects greater impairment in daily life activities. A decrease in score indicates improvement in functional capacity. The minimal clinically important difference (MCID) is generally considered to be 2 to 3 points.
Trial sites (1)
Facility City Region Status
Clinique Saint-Roch - LNA SANTE
Roncq
France
More LNA SANTE trials in France
Other trials for the same condition
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
Cookie Policy · Privacy Policy
Essential only
Accept all